University of Mississippi

eGrove
Electronic Theses and Dissertations

Graduate School

2014

Is Marital Status A Determinant Of Self-Monitoring Of Blood
Glucose?
Jasmine Evelyn Dixon Jones
University of Mississippi

Follow this and additional works at: https://egrove.olemiss.edu/etd
Part of the Nutrition Commons

Recommended Citation
Dixon Jones, Jasmine Evelyn, "Is Marital Status A Determinant Of Self-Monitoring Of Blood Glucose?"
(2014). Electronic Theses and Dissertations. 593.
https://egrove.olemiss.edu/etd/593

This Thesis is brought to you for free and open access by the Graduate School at eGrove. It has been accepted for
inclusion in Electronic Theses and Dissertations by an authorized administrator of eGrove. For more information,
please contact egrove@olemiss.edu.

IS MARITAL STATUS A DETERMINANT OF SELF-MONITORING OF BLOOD
GLUCOSE?

A Thesis
presented in partial fulfillment of requirements
for the degree of Master of Science
in the Department of Nutrition and Hospitality Management
The University of Mississippi

by
JASMINE DIXON JONES
April 2014

	
  
	
  

Copyright Jasmine Dixon Jones 2014
ALL RIGHTS RESERVED
	
  
	
  

ABSTRACT
Glycemic control is one of the most important aspects of diabetes management and is
necessary for the prevention or delay of complications associated with diabetes mellitus (DM).
Self-monitoring of blood glucose (SMBG) is a technique used achieve glycemic control by
revealing day-to-day changes in blood glucose levels. Since marriage protective effects have
been shown for mortality, especially for men, it is useful to determine whether a similar
relationship is found between marriage and SMBG. The purpose of this study is to examine
whether marital status is a determinant of SMBG, when controlling for other variables, and
whether marital status determines SMBG differently for males and females.
Demographic data were obtained from 465 individuals who self-reported a diagnosis of
DM in the continuous NHANES 2009-2010, along with data about treatment, condition, and
self-management practices. Using logistic regressions, significant predictors were identified for
SMBG.
One-third (36%) of adults with diabetes in the U.S. population do not self-monitor their
blood glucose level at least 1 time/day. A minority (29.5%) of females who are not married do
not self-monitor daily, while this is true for nearly half (47.6%) of males who are not married.
Insulin use is the major determinant for SMBG, along with age, race/ethnicity, and patient DM
education. Marital status was found to be a significant predictor for SMBG among males, only
when insulin and pills use were not included in the regression. Marital status was not identified
as a significant predictor of SMBG for females.
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Although marital status is independently associated with reduced mortality, a similar
protective relationship is not shown between marital status and SMBG. Since SMBG may be a
useful in the achievement of glycemic control, individuals with diabetes should incorporate this
practice into their regimens for diabetes self-management.
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CHAPTER I - INTRODUCTION
Diabetes mellitus (DM) refers to a group of diseases that are characterized by
hyperglycemia as a result of deficiencies with insulin production, alone, or accompanied with
insulin sensitivity. Approximately 8.3% of the United States (U.S.) population is affected by
DM, as 18.8 million persons have been diagnosed, while an estimated 7 million persons are
believed to have undiagnosed DM (Centers for Disease Control and Prevention (CDC), 2011).
Persistent hyperglycemia is associated with adverse effects on, essentially, every body system
including cardiovascular disease (CVD), nephropathy, neuropathy, and retinopathy. Such
complications can ultimately lead to chronic illnesses and death (Shrivastava, Shrivastava, &
Ramasamy, 2013). However, the prevention or delay of complications associated with DM may
be achieved with intensive glycemic control (Ohkubo et al., 1995; R. C. Turner, Holman, Cull, &
Stratton, 1998).
The treatment and management of DM is quite complex and meticulous. Furthermore,
persons with DM or their family members provide 95% or more of the care involved with
disease management. The self-management of DM consists of: self-monitoring of blood glucose
(SMBG), tailoring nutrition to daily needs, regular physical activity, and adherence to
medication regimens in order to achieve adequate glycemic control. Self-management should
also involve understanding and integrating each component of care in order to make the
appropriate adjustments according to daily needs (Sigurardóttir, 2005).
The two main techniques used to monitor glycemic control include HbA1c testing and
SMBG, which most often involves using “point of care” devices known as portable glucose
meters to obtain a small amount of blood from the arm or finger, usually between one and four
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times a day, to test the level of blood glucose concentration (Montagnana, Caputo, Giavarina, &
Lippi, 2009). SMBG is considered the cornerstone of DM management, as it provides relevant
information that helps achieve glycemic control by reflecting the effectiveness of treatment,
exposing the potential need for adjustments, and providing information about daily variations of
glycemic changes that is not available with HbA1c testing. The efficacy of SMBG is
controversial but has been shown to be associated with improved glycemic control, improved
health outcomes, and reduced mortality (Martin et al., 2006).
Despite the debates about the effectiveness of SMBG, the American Association of
Clinical Endocrinologists (AACE) Diabetes Care Plan Guidelines recommend that individuals
using insulin should monitor blood glucose at least two times a day or before each injection of
insulin. However, the recommended frequency for SMBG remains unclear and depends on the
type of pharmacotherapy used to help achieve target blood glucose levels. Generally, SMBG is
not required for individuals exclusively taking oral anti-hyperglycemic agents that do not include
sulfonylureas or glinides to regulate blood glucose, as these agents are less likely to cause
hypoglycemia. Individuals who rely on insulin therapy should self-monitor blood glucose more
frequently (Handelsman et al., 2011; Nathan et al., 2009). However, a study investigating the
frequency of SMBG and its relationship with glycemic control showed that greater than ¼ of
persons using insulin did not monitor blood glucose level at least once per day. Sixty-five
percent of the persons using oral agents did not monitor at least one time daily, while most
individuals treated with diet alone did not monitor glycemic levels (Harris, Cowie, & Howie,
1993; Harris, 2001).
An association between social support and DM self-management behaviors has been
widely researched, yielding at least minimal evidence of a positive influence. The different types
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of social support include: family support, peer support, and healthcare provider support with
further distinctions between structural and functional social support (Chew, Khoo, & Chia, 2011;
Gao et al., 2013; Strom & Egede, 2012; Tang, Brown, Funnell, & Anderson, 2008). DunbarJacob and Schlenk (2001) suggest patient adherence as the link between social support and
improved health. Adherence refers to an individual’s acceptance of illness and the willingness to
follow through with treatment recommendations and regimens for health maintenance
(DiMatteo, 2004). Social support may be essential to accomplishing adequate SMBG, in order to
achieve positive health outcomes. Despite the extensive research about the impact of social
support on DSM, there is very little evidence about the relationship between marriage and
SMBG. The existing literature examines the impact of marriage quality, marriage satisfaction,
and spousal involvement (Trief, Himes, Orendorff, & Weinstock, 2001; Trief, Ploutz-Snyder,
Britton, & Weinstock, 2004).
More specifically, it is widely accepted that marital status, a variation of structural social
support, is associated with longevity and improved health. This trend remains true across
populations, both globally and in the United States (Hu & Goldman, 1990). However, a recent
review of prospective studies yields inconsistent findings concerning differentiations among men
and women, each type of unmarried status (i.e., never married, widowed, and
divorced/separated), and age groups (Rendall, Weden, Favreault, & Waldron, 2011).
The purpose of this study is to examine the association between marital status and selfmonitoring of blood glucose. This research aims to answer the following research questions:
1. What are the determinants of self-monitoring of blood glucose?
2. Is marital status a determinant of self-monitoring of blood glucose when controlling for

other determinants?	
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3. Does marital status determine self-monitoring of blood glucose differently for males and
females?
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CHAPTER II – LITERATURE REVIEW
This chapter contains an overview of the literature regarding the pathophysiology and
epidemiology of DM. The overview is followed by an exploration of literature addressing selfmonitoring of blood glucose. Lastly, this review will end with a summary of studies that
investigate the relationship between marital status and mortality.
TYPES OF DM
Type 1 Diabetes Mellitus (T1DM)
There are several different types of DM that are evident by high levels of glucose in the
blood including type 1, type 2, gestational, and other rare types of diabetes mellitus. Because this
study mainly focuses on types 1 and 2, there will only be a brief discussion of gestational and the
other rare types of diabetes mellitus.
T1DM is an autoimmune disorder in which an individual’s pancreatic beta cells are destroyed as
a result of some combination of genetic and environmental interactions. As a result, individuals
who are diagnosed with T1DM lack the ability to produce the hormone, insulin, which is
responsible for the regulating the amount of glucose in the blood. The specific combinations of
environmental and genetic interactions that cause T1DM remain unknown (Gan, AlbaneseO’Neill, & Haller, 2012). Previously known as insulin-dependent diabetes mellitus (IDDM) or
juvenile diabetes, T1DM is usually diagnosed among children and young adults. This form is
only found in approximately 5% of all adults diagnosed with DM. Currently, there are no known
strategies to prevent or cure T1DM (Centers for Disease Control and Prevention (CDC), 2011).
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As a result, the main goal of treatment is to improve the quality of life among individuals living
with the disease. In order to prevent or delay complications and sustain survival, individuals with
T1DM must rely on exogenous insulin therapy, along with the help of healthcare professionals,
to regulate and control blood glucose levels (Gan et al., 2012).
Type 2 Diabetes Mellitus (T2DM)
T2DM is a metabolic disorder characterized by high levels of glucose in the blood, or
hyperglycemia, as a result of insulin resistance. This insulin resistance usually occurs before the
disease develops, occurring when an individual’s body cells do not utilize insulin properly.
T2DM is usually prefaced by a condition called prediabetes in which blood glucose levels are
higher than normal but too low for a diagnosis of DM. This evolutionary process from normal
glucose tolerance to impaired glucose tolerance and eventual T2DM is the result of insulin
resistance that leads to an eventual defect of insulin production by the pancreatic beta cells. The
pancreas is required to produce elevated amounts of insulin in order to regulate blood glucose
levels and, consequently, is unable to achieve adequate, insulin production that overcomes the
resistance. T2DM is commonly treated with diet therapy, physical activity, oral antihyperglycemic agents such as Metformin, and insulin therapy (Centers for Disease Control and
Prevention (CDC), 2011; Simmons, 2010; Surampudi, John-Kalarickal, & Fonseca, 2009).
As the most common form of diabetes mellitus, T2DM accounts for approximately 90%
to 95% of all the cases of diabetes mellitus. Formerly known as non-insulin-dependent diabetes
mellitus (NIDDM) or adult onset diabetes, T2DM has several associating risk factors including
race/ethnicity, age, and family history of DM, along with the history of gestational diabetes,
obesity, and sedentary lifestyle. This form of DM is rare among children and young adults but is
increasingly becoming more prevalent among children and adolescents who are African
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Americans, American Indians, Asians, and Hispanics/Latin Americans. These races/ethnicities
are at a greater risk of developing T2DM and its associating consequences (Centers for Disease
Control and Prevention (CDC), 2011).
Other Types of Diabetes Mellitus
Gestational diabetes mellitus (GDM) is a condition of glucose intolerance that occurs or
is, initially, identified and diagnosed during pregnancy. African American, Hispanic/Latin
American, and American Indian women are at a greater risk for developing this form of diabetes
mellitus. A woman’s risk of developing GDM is enhanced even more with obesity and a family
history of diabetes mellitus. Treatment is required for blood glucose regulation in order to
prevent harm in the mother and the infant (Centers for Disease Control and Prevention (CDC),
2011).
GDM, seemingly, occurs as a result of the same pathophysiological processes and
pathways as with other types of DM that develop outside of pregnancy (type 1 and type 2 DM).
Therefore, women with GDM have a high risk of developing T2DM after pregnancy. A review
of longitudinal studies reveal that most women with GDM experience the progression to T2DM,
but an estimate of only 10% of women are diagnosed soon after delivery (Buchanan & Xiang,
2005).
There are other rare types of DM that are precipitated as a result of particular
circumstances including surgery, illnesses, infections, pancreatic disease, and taking
medications. Additionally, specific genetic combinations may trigger the onset of uncommon
forms, such as maturity-onset DM during youth. There are infrequent forms of DM that may
occur as a result of gene mutations, neonatal glucose intolerance, and atypical maladies of the
immune system. These and other rare forms of DM only account for 1% to 5% of all known
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incidents of DM(Centers for Disease Control and Prevention (CDC), 2011; Mihai, Mihai,
Cijevschi-Prelipcean, & Lăcătuşu, 2011).
DM is a growing epidemic in the U.S. and around the world. Furthermore, the prevalence
of DM among adults has steadily increased. The prevalence rates are expected to continue
increasing, due to decreased levels of physical activity and increased rates of obesity. In 2000, 11
million Americans were diagnosed with DM, yielding a prevalence of 4%. By 2010, there were
almost 19 million known cases of DM in the U.S., while there is a projection of an increase to 29
million by the year of 2050 to yield a prevalence of 7.2%, based on emerging trends and
prevalence data for age-, sex-, and race-specific rates of diagnosed DM from the National Health
Interview Survey and projected population demography data from the Bureau of Census. Also,
the rates of DM have remained higher among non-Hispanic African Americans and MexicanAmericans when compared to non-Hispanic whites (Harris et al., 1998). The projection reveals
an expectation of the greatest increases appearing among African-American males and females,
75 years or older (Boyle et al., 2001; Wild, Roglic, Green, Sicree, & King, 2004).
The projections of increasing global DM prevalence rates are parallel to that of the U.S.
Based on a review of studies and prevalence data from 91 countries, the global prevalence of
DM will reach 7.7% by 2030 with 439 million cases of DM among adults. This is an indication
of the growing and concerning burden of DM, specifically for developing countries.
Additionally, these estimates are not based on the projections of obesity and may not provide an
accurate and lucid depiction of the growing “diabetes mellitus epidemic.” Instead, the number of
cases of DM worldwide may greatly exceed the projected numbers and pose a larger and more
dangerous threat to society than is currently expected. Therefore, it is essential to allocate
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resources and efforts, effectively, in order to reduce the future burden of DM among adults and
children (Shaw, Sicree, & Zimmet, 2010; Wild et al., 2004).
COMPLICATIONS ASSOCIATED WITH DM
Previous studies show an association between hyperglycemia and microvascular and
macrovascular complications (Klein, 1995; Pirart, 1978; Standl et al., 1996). Microvascular
complications refer to nephropathy and chronic kidney disease, sensory neuropathy, amputations
of the lower extremities, and retinopathy. On the other hand, macrovascular complications
include chest pain, myocardial infarction, CVD, congestive heart failure, and stroke. Increased
levels of hyperglycemia are associated with an increased risk of such complications and
mortality as a result of all causes(Adler et al., 1997; Groeneveld, Petri, Hermans, & Springer,
1999; R. Turner et al., 1998). The increased risk is, generally, associated with drastically high
concentrations of blood glucose. Additionally, hyperglycemia, manifested as ranges of
hemoglobin A1c (HbA1c) between 6% and 11%, is associated with the further development of
microvascular complications in individuals with T1DM (Diabetes Control and Complications
Trial Research Group, 1996).
Some complications associated with DM may be classified as sporadic, as they are
recurring and require repetitive treatment. For example, an individual with DM may experience
foot ulcers many times after diagnosis. On the other hand, certain complications are progressive,
resulting in further damages that yield additional, long-term disabilities. One common example is
chronic kidney disease that progresses to end-stage renal disease (ESRD). According to data
from the National Health and Nutrition Examination Survey (NHANES), the prevalence of
chronic kidney disease, amputations or medical conditions of the feet, and eye damage (all
microvascular complications) are drastically higher than that of macrovascular complications.
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Other DM-related complications include reduced resistance to bacterial and viral infections (i.e.
pneumonia and influenza), dental disease, and the delivery of infants who are large-forgestational age, along with other birth complications, among pregnant women (American
Association of Clinical Endocrinologists, 2007; Deshpande, Harris-Hayes, & Schootman, 2008).
Whether recurrent or progressive, DM-related complications contribute to the rising
economic burden of DM and the widespread loss of functionality among individuals with DM.
By the year 2007, the economic burden of both prediabetes and DM in the U.S. exceeded $215
billion, as a result of decreased productivity and increased healthcare costs. The average yearly
cost for each case of T1DM nearly doubles that of T2DM. However, the number of cases of
T2DM greatly exceeds the number of T1DM cases. Each American has a burden cost, whether
or not he has been diagnosed with DM, and these alarming, rising costs highlight the importance
of DM prevention, along with, quality and effective treatment (Dall et al., 2010).
TREATMENT FOR DM
Multidisciplinary Team
Each individual diagnosed with DM should have a comprehensive treatment plan that
considers his/her medical history, relevant behavior and risk factors, ethnic and cultural
background, and environment. A multidisciplinary team is best for the delivery of quality and
effective care for those with DM. The team should include a primary care physician,
endocrinologist, and nurse practitioner. The team can also consist of a registered nurse, certified
diabetes educator, registered dietitian, exercise specialist, and mental health care professional.
The opportunity to work with an exhaustive team of healthcare providers allows individuals to
acquire a wealth of knowledge about an array of different topics, addressing their general and
unique health concerns. Some health care providers are able to devote more time and attention to
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specific topics that may positively influence health outcomes. According to individuals with
diabetes mellitus, CDEs often provide more practical education than physicians (Handelsman et
al., 2011).
Glycemic and Other Goals
The association between hyperglycemia and diabetes mellitus-related microvascular and
macrovascular complications has been widely accepted. Additionally, efforts and therapies used
to achieve glycemic control, including intensive insulin therapy, have also been shown to lower
the rates of microvascular complications and some cardiovascular illnesses associated with DM.
There are two major methods used to monitor blood glucose levels and achieve glycemic control,
which includes testing HbA1c levels and the self-monitoring of blood glucose (SMBG). HbA1c
refers to the proportion of hemoglobin that is a product of glucose saturating erythrocytes
(glycation), reflecting the mean blood glucose level over 2-4 months since erythrocytes have a
general life span of 120 days (American Diabetes Association, 2011; Jeffcoate, 2004).
A review of supporting evidence yields conflicting specific targets for glycemic control.
The fasting plasma glucose (FPG) of healthy persons does not rise above 99mg/dL or above 120
mg/dL after meals (Handelsman et al., 2011). Nonetheless, a significant association has been
shown between T2DM and FPG levels of 87 mg/dL and 94 mg/dL (Hayashino et al., 2007;
Tirosh et al., 2005). Due to highly varying conditions, glycemic goals should be individualized
and feasible. Each individual has different amounts of risk factors and comorbidities, along with
different psychosocial and economic states. According to the AACE, most non-pregnant
individuals with DM should aim for HbA1c at or below 6.5%, while reducing the risk of
hypoglycemia as much as possible. Glucose concentrations 2 hours after eating should remain
less than 140 mg/dL in order to accomplish this glycemic goal, while FPG should remain less
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than 110 mg/dL. Individuals with extensive comorbidities, prevalent complications, and severe
hypoglycemia may require a less restrictive glycemic goal (HbA1c 7% – 8%), as the specific
goals are much more difficult to achieve despite intensive glycemic control (Handelsman et al.,
2011). On the other hand, the American Diabetes
The American Diabetes Association (ADA) states that T2DM is diagnosed when the
fasting plasma glucose level is ≥ 126 mg/dL, the post-prandial plasma glucose level is ≥ 200
mg/dL, or a random plasma glucose level ≥ 200 mg/dL accompanied by regular symptoms of
hyperglycemia. The recommended goals from ADA include an HbA1c level of 7%, a preprandial plasma glucose level of 70-130 mg/dL, and a post-prandial plasma glucose level of <
180 mg/dL(American Diabetes Association, 2011).
Evidence shows a strong association between previous hyperglycemia and DM-related
complications, among individuals with T2DM. However, the risk is reduced with any reduction
in HbA1c. Each 1% reduction in HbA1c lowers the risk of all DM-related end-points, death,
myocardial infarction, and microvascular complications. The lowest risk of complications is
found among individuals with HbA1c below 5.0%(Holman, Paul, Bethel, Matthews, & Neil,
2008; Khaw et al., 2004; R. C. Turner et al., 1998). Risk factors for CVD should be reduced, as it
is a primary cause of death among those with DM. In addition, low-density lipoprotein
cholesterol should remain less than 100 mg/dL, and less than 70 mg/dL for those with CVD or at
high risk for developing CVD. High-density lipoprotein should exceed 40 mg/dL in men and 50
mg/dL in women (Handelsman et al., 2011).
Comprehensive Care Approaches
Several strategies may be used to achieve the designated goals and targets for optimal
health outcomes associated with DM care, including strategic lifestyle changes and
pharmacotherapy. Registered dietitians/nutritionists or knowledgeable physicians use medical
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nutrition therapy to develop highly individualized plans that address several topics essential to
glycemic control and the reduction of risks associated with complications and CVD. The
dietitian or physician, generally, recommends consistent carbohydrate intake, in addition to an
insulin dosage that corresponds with a specific carbohydrate intake pattern. This method is often
referred to as carbohydrate counting. Healthy eating, weight management, adequate protein
intake, and limitation of high glycemic index foods are also topics of education. Other healthcare
professionals may also address adequate sleep, cessation and avoidance of tobacco products, and
stress reduction (Handelsman et al., 2011).
Regular physical activity has been shown to improve glycemic control. Despite the
difficulty of determining the effect of exercise alone, physical activity, including aerobic exercise
and strength training, contributes to the weight management aspect of DM management when
coupled with calorie restriction. The suggested 150 minutes per week of moderately intense
exercise is a widely accepted recommendation. This includes brisk walking and other
comparable activities. Among those with diabetes mellitus, flexibility and strength training
activities should also be considered. Professionals should evaluate each individual to determine
potential restrictions and limitations related to physical activity and help each person develop
goals and a plan of action to gradually achieve those goals, with an exercise prescription
(Handelsman et al., 2011).
Individuals, using strategies to achieve specific glycemic goals, must take care to reduce
the risk of hypoglycemia, or low blood glucose, which causes recurring morbidity and occasional
mortality. For individuals with T2DM, this involves determining the appropriate oral antihyperglycemic agents, as differences exist between the various available agents. Metformin has
intermediate glycemic control durability (Kahn et al., 2006). However, the addition of a
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sulfonylurea to Metformin greatly increases the risk of hypoglycemia compared to the use of
Metformin, alone, or the use of sulfonylurea with thiazolidinedione, another oral antihyperglycemic agent (Belsey & Krishnarajah, 2008). Other agents include dipeptidyl peptidase 4
inhibitors and bromocriptine mesylate, which are not associated with an increased risk of
hypoglycemia. Practitioners should also consider whether the FPG or postprandial glucose is the
main target, while considering the common adverse effects associated with each oral agent, in
order to determine the best selection for each individual (Handelsman et al., 2011).
For individuals with DM, the use of any type of insulin therapy increases the complexity
of disease management. Insulin is required for all individuals with T1DM, while insulin therapy
should also be considered for individuals with T2DM, particularly those who have not achieved
glycemic control with oral anti-hyperglycemic agents, alone. A physiologic insulin regimen
providing basal and prandial insulin, such as multiple daily injections (MDI) or continuous
subcutaneous insulin infusion (CSII) is recommended. MDI refers to one or more basal insulin
injections to regulate blood glucose levels overnight and between meals, in addition to prandial
insulin injections before each meal to regulate blood glucose levels related to eating. MDI
regimen, often, yields episodes of hypoglycemia, especially among individuals who experience
difficulty with adherence to the regimen. CSII, also known as insulin pump therapy, refers to the
continuous infusion of short-acting insulin delivered under the skin. It is particularly useful for
those with T1DM who are ambitious and well educated about DM management. Success with
CSII requires extensive education, several reevaluations, and a knowledgeable practitioner or
physician (Handelsman et al., 2011).
Additionally, insulin analogues may be used to achieve glycemic control. Premixed
insulin is available in combinations of 70% intermediate-acting insulin and 30% regular acting
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insulin, providing blood glucose regulation between meals and after meals. The dosage of
premixed insulin regimen is not flexible, as the injection doses cannot be changed. Premixed
insulin therapy is not always successful in achieving glycemic goals and requires increased doses
or frequency. However, hypoglycemia and weight gain are adverse consequences of such
increases.
Instead, basal-bolus insulin therapy provides more flexibility and is useful for individuals
with irregular mealtimes. This regimen involves 4 daily injections that provide basal and prandial
insulin. The dosage of insulin depends on body weight, level of insulin resistance, and the
amount of carbohydrate consumption at each meal. Adjustments to each basal and prandial
dosage should be made to achieve glycemic control, while reducing the risk of hypoglycemia
(Handelsman et al., 2011).
Diabetes Self-Management
The high rate of morbidity and complications associated with DM can be delayed and
prevented by achieving and maintaining glycemic control with appropriate DM self-management
(Ohkubo et al., 1995; R. C. Turner et al., 1998). Diabetes self-management (DSM) behaviors
include healthy eating (including limiting high fat foods and caloric restrictions for overweight
and obese individuals), physical activity, SMBG, and foot care (Shrivastava et al., 2013). Selfmanagement of DM should also consist of acknowledging and treating symptoms related to DM,
seeking appropriate medical care for specific health problems, and engaging in behaviors that
reduce the risk of developing further complications and comorbidities (Glasgow & Strycker,
2000; Goodall & Halford, 1991; Shrivastava et al., 2013). Previous studies that explore effective
DSM reveal adequate health professional advice (Agborsangaya et al., 2013; Sigurardóttir,
2005). Other determining elements include family behavior among older Mexican Americans
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and influences of spirituality, stress, and multi-caregiving responsibilities among AfricanAmerican women (Samuel-Hodge et al., 2000; Wen, Shepherd, & Parchman, 2003).
SELF-MONITORING OF BLOOD GLUCOSE (SMBG)
Glycemic control and individual blood glucose targets can be achieved with
comprehensive care and effective DSM. According to the ADA, daily blood glucose values
generate reliable information that may aid with adjusting treatment regimens and insulin doses.
SMBG provides more useful information about daily (Nathan et al., 2009). When used properly,
SMBG is an essential component of modern DM management and a source of meaningful
clinical data that can contribute to adequate glycemic control and positive health outcomes.
Regarded as the cornerstone of DM management, SMBG is especially useful among individuals
with T1DM, those receiving insulin therapy, and those with a history of asymptomatic
hypoglycemia (Nathan et al., 2009). A more recently developed method of SMBG involves
wearing a continuing glucose monitoring system that is known to detect glycemic variations that
are often missed with the conventional method of SMBG, potentially changing the course of DM
management in the future (Boland et al., 2001).
SMBG is used to achieve and maintain glycemic control, expose problems with DM
management, identify and prevent hypoglycemia and severe hyperglycemia, increase motivation
among individuals with DM, and improve the individual’s understanding of DM and its
management (Karter et al., 2001; Walford, Gale, Allison, & Tattersall, 1978). A review of
studies shows a greater reduction in HbA1c when SMBG is included in a multi-component
treatment regimen than in those that do not include it. However, findings from a different study
show no relationship between HbA1c and SMBG among participants (Davis, Bruce, & Davis,
2006). Additionally, a systematic review of studies shows an inadequate level of effectiveness of
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SMBG on glycemic control. Researchers propose that improvements in glycemic control as a
result of SMBG occur only in the context of appropriate education among persons with DM and
their healthcare providers (Clar, Barnard, Cummins, Royle, & Waugh, 2010). Epidemiologic
data, on the other hand, suggests an association between SMBG and reduced rates of DM-related
morbidity and all-cause mortality among persons with T2DM, regardless of the type of
pharmacotherapy (Martin et al., 2006). Although, studies reveal at least minimal evidence of an
association between SMBG and improved glycemic control and health outcomes, evidence
shows a lack of adherence to SMBG among Americans with DM. By investigating the
relationship between glycemic control and SMBG among individuals with DM in the U.S.
population, researchers found that greater than twenty-five percent of those using insulin did not
monitor blood glucose level at least once per day. Sixty-five percent of the persons using oral
agents did not monitor at least one time daily, while most individuals treated with diet alone did
not monitor glycemic levels (Harris et al., 1993; Harris, 2001).
There is much debate about the effectiveness of SMBG among individuals with T2DM
who are not using insulin. Individuals using oral anti-hyperglycemic agents and/or diet,
exclusively, are encouraged to use SMBG to determine success with achieving target blood
glucose values and the possible need for treatment adjustments. However, several researchers
argue that the use of SMBG among individuals not using insulin should be considered in the
context of cost and inconvenience, suggesting that SMBG may be clinically beneficial but not
cost-effective or the best use of time. Structure and education are identified as essential
components to the success of SMBG among these persons. Other outcomes, such as quality of
life and patient satisfaction, are also recognized as determinants of effective SMBG in those not
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using insulin (Cameron, Coyle, Ur, & Klarenbach, 2010; Polonsky & Fisher, 2013; Welschen et
al., 2005).
Several studies that explore the factors influencing the frequency of SMBG among
individuals with DM in the U.S. reveal significant predictors of SMBG. Using cross-sectional
and longitudinal data, along with multivariate and linear regression models, findings indicate
significant associations between SMBG and several determinants including the duration of the
disease, insulin use, age, gender, race/ethnicity, education, English-communication ability,
smoking status, and alcohol consumption. Other determinants of SMBG include whether persons
have had a DM education class and the frequency of physician visits for DM care, specifically
(Harris et al., 1993; Karter, Ferrara, Darbinian, Ackerson, & Selby, 2000). SMBG is less
frequent among older individuals, those with lower neighborhood socioeconomic status, and
those who have had fewer HbA1c tests and physician visits (Adams et al., 2003). Additionally,
the frequency of SMBG has been shown to decrease with increasing age for individuals with
T2DM (Evans et al., 1999). When compared to non-Hispanic whites and Mexican Americans,
African Americans are 60% less likely to monitor their blood glucose at least once a day. In
comparison to those with lower education levels, individuals with a college education are 80%
more likely to monitor their blood glucose levels at least once a day (Harris et al., 1993).
Evidence suggests that all types of social support have a positive influence on improving
DM self-management behaviors including adherence to treatment recommendations, nutritional
selections, and physically active lifestyles. Additionally, social support has been shown to be
positively associated with the improved ability to make healthcare decisions, enhanced
psychosocial health, and less mortality (Chew et al., 2011; Gao et al., 2013; Strom & Egede,
2012; Tang et al., 2008).
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Despite the extensive research about social support and its impact on DM selfmanagement, there is little existing literature that addresses the impact of marriage. Previous
studies that have examined the relationship between marriage and DM management investigate
marriage quality and satisfaction (Trief et al., 2001; Trief et al., 2004). Moreover, to my
knowledge, no previous study has extensively explored the association between marital status
and SMBG, investigating differences between male and female and each category of marital
status (single, married, divorced, separated, widowed, never married).
It has been long accepted that marriage is associated with lower rates of mortality and
better health outcomes(Hu & Goldman, 1990). Kaplan and Kronick (2006) explored the
relationship between marital status and all-cause mortality, along with cause-specific mortality,
using data from the US national health interview survey and the national death index. The six
categories of specific causes of death included infectious disease, cancer, cardiovascular disease,
pulmonary disease, external causes such as homicides/suicides and accidents, and all “other”
causes. By estimating the association with multivariate logistic regressions, findings showed that
individuals who were never married had a greater risk of all-cause mortality (OR=1.58, CI 1.39
to 1.78) than those who were divorced or separated (OR=1.27) and widowed (OR=1.39). The
researchers referred to this manifestation as the “never-married penalty.” In addition to marital
status, age was the strongest predictor of mortality, along with other determinants such as
gender, income, race/ethnicity, and disability status. Also, those who were never married were
over four times more likely to die as a result of infectious diseases. Being never married was a
greater risk factor for the remaining causes of death excluding CVD, cancer, and pulmonary
disease. This evidence contradicts the findings of several other studies, which indicate the
divorced/separated or widowed statuses as the greatest risk factors of mortality among all marital
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states. However, it is difficult to draw conclusions of a causal relationship between marriage and
lower mortality, or a protective effect of marriage, from cross-sectional data. An alternate
conclusion addresses the potential concept of positive selection of healthier and wealthier
individuals into marriage (Goldman, 1993). Yet, the protective effect of marriage remains
evident after controlling for characteristics such as income, education, and health, which are
believed to select individuals into marriage (Espinosa & Evans, 2008). Prospective data sets that
reflect the individual-level are superior, yielding stronger evidence than that of cross-sectional
data. However, studies that investigate mortality differences between men and women and the
different unmarried statuses using individual-level, prospective data reveal inconsistent findings
that identify the marriage protective effect for men and women (Lillard & Waite, 1995) or for
men only (Zick & Smith, 1991), while there was no difference found between genders for oldage mortality (Manzoli, Villari, Pirone, & Boccia, 2007).
Rendall et al. (2011) propose two potential sources of the inconsistent findings, including
the use of baseline, covariate data sets that do not appropriately reflect the time of exposure to
mortality and the inappropriate use of statistical tests, failing to perform proper between group
statistical analyses. As a result, they planned to resolve these inconsistent findings by using timevarying data from the U.S. Survey of Income and Program Participation and logistic regression
models to estimate the yearly probability of death. The predictor variables included age, calendar
year, race/ethnicity, educational attainment, working status, income earnings, and disability
status. Also, statistical tests were performed to determine differences between the married and
unmarried status, in addition to determining differences between ages, gender, and each
unmarried status (never married, divorced/separated, and widowed). The findings showed strong,
significant associations between being married and a lower probability of death among
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individuals ages 25-64 which decreased after controlling for socio-demographic characteristics
that changed over time. The protective effects of marriage disappeared at older ages for both men
(89 years) and women (84 years). Additionally, the survival benefit of marriage was lower for
women than for men, but this occurrence decreased with age. There was no difference found
between unmarried statuses among individuals who were 25 years of age, excluding an existing
difference between divorced/separated men and widowed individuals. However, a greater risk of
mortality into older age was found for divorced/separated men and women than that of men and
women older than 25 years, who were never married or widowed. Similar results were found for
divorced and separated men and women ages 65 and older. These findings support both proposed
interpretations of a consistent protective effect of marriage that decreases with age and the
selection of individuals into marriage, due to socio-demographic characteristics. Lastly, the
findings give weak evidence of mortality differences between each unmarried status.
Summary
The growing prevalence of DM, in the U.S. and worldwide, and its associating
complications have increased the economic burden, and the projected cost is expected to
continue rising at an alarming rate. The treatment goal for individuals with DM is to achieve and
maintain strict glycemic control, which often consists of a complex regimen. DM selfmanagement, including SMBG, eating a healthy diet, being physically active, and taking
medications appropriately, constitutes a large proportion of DM care. SMBG, the cornerstone of
DM management, provides essential information for successfully achieving and maintaining
glycemic control. The efficacy of SMBG is controversial, particularly among those not using
insulin, but has been shown to improve individuals’ level of understanding and glycemic control
and is highly recommended by healthcare providers. Despite the evidence of its benefits, there is
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a lack of SMBG among individuals with diabetes mellitus, especially older adults and African
Americans. Social support has been identified as a determinant of DM self-management,
including SMBG, but there is very little existing literature that addresses the relationship
between marriage and SMBG. Marriage, a type of structural social support, is associated with
less mortality, with an additional survival advantage seen among men. There is inconsistent
evidence regarding mortality differences between men and women and the different categories of
the unmarried state (never married, divorced/separated, and widowed). Exploring an association
between marital status and SMBG may provide more information about methods used to
improve self-management among individuals with DM.
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CHAPTER III - RESEARCH DESIGN AND METHODS
	
  
The National Health and Nutrition Examination Survey (NHANES) is a populationbased, survey designed to collect data regarding the health and nutrition of non-institutionalized
adults and children in the United States (U.S.). The survey is conducted by the National Center
for Health Statistics (NCHS) as a part of the Centers for Disease Control (CDC). The NHANES
is exceptional, as it is a national survey that assesses health and nutritional information using
both face-to-face interviews and physical examinations. Each participant is involved in a home
interview about health, disease history, and diet, while the clinical examination involves medical
and physiological measurements in addition to laboratory tests. HbA1c, which is used to reflect
the plasma glucose levels over the past 120 days, was one of the laboratory tests measured
during the separate clinical examination, along with body mass index (BMI). Self-reported data,
laboratory data, and clinical data are obtained from a representative sample of U.S. children and
adults.
Cross-sectional data from the continuous NHANES 2009-2010 were analyzed to identify
determinants for SMBG among participants with DM. More recent data has been released, but at
the time of this study NHANES 2009-2010 was the most recent dataset released in its entirety.
Analyses were conducted to determine whether marital status is a significant predictor of SMBG
behavior and to examine whether marital status determines SMBG differently for males than for
females.
The continuous NHANES 2009-2010 had a sample of 10,537 participants. The sample
for this study was reduced to 739 participants, who reported having received a diagnosis of DM
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by a doctor or health professional. Those who were under 20 years of age were excluded from
the sample, yielding 725 participants. Also, two participants who refused to provide marital
status data were excluded. Those whose income and BMI data were missing were also excluded,
leaving a remainder of 668 participants. Since age is top coded at 80 years, all participants who
were 80 years and older were excluded (69 participants). Additionally, participants who reported
“I don’t know” as a response for age at diagnosis, along with those with missing treatment and
DM education data were excluded (131 participants). Lastly, those with missing education,
HbA1c, and SMBG data were excluded. The remaining 465 participants were included in the
analysis. IRB approval was not required due to the use of secondary data with no identifiers.
Measures
	
  

Variables were strategically extracted from the core survey by isolating a group of

questions that addressed DM including diagnosis, medical care, and self-management practices.
The extracted variables can be divided into two main components: a screening question to
identify all individuals with DM and detailed questions about the participants’ condition. Also,
demographic data were extracted from the core survey, including marital status. Additionally, the
two variables extracted from the clinical examination were HbA1c and BMI. Duration of DM
was determined by subtracting the age at diagnosis from the age at the time of screening. The
frequency of self-monitoring of blood glucose (SMBG), the dependent variable, was determined
by the participants’ responses to the question, “How often do you check your blood for glucose
or sugar? Include times when checked by a family member or friend, but do not include times
when checked by a doctor or other health professional.” Each SMBG response was transformed
to reflect an annual unit of measure. Then, the variable was dichotomized into the derived
variable, checks daily, where ≥ 365 = 1 and < 365 = 0. This method was validated by comparing
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the number of participants (297/63.87%) who reported self-monitoring their blood glucose ≥ 1
time per day to the number of those (299/64.3%) with ≥ 365 as a response for checks daily,
which resulted in a correlation of 0.9933126.
Statistical Analyses
Binary logistic regression analyses were used to identify the determinants of SMBG,
among those with DM. First, marital status, age, race/ethnicity, education, income, DM
education, and duration of diabetes variables were included in the regression as explanatory
variables for all participants. Then, additional covariates of HbA1c, taking insulin, and taking
anti-hyperglycemic pills were entered into the regression, along with the previously mentioned
covariates, to examine whether the determinants change when controlling for DM conditions. In
addition, logistic regressions were run in the same manner as mentioned above for females and
males, separately, in order to examine whether marital status determines SMBG differently for
men and women. Statistical significance was defined as P < .05, using a one-tailed test. SPSS
Statistics 20.0 was used to perform the statistical analysis.
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CHAPTER IV- RESULTS
Sample Characteristics
The characteristics of the 465 participants with diabetes in the sample are summarized in
Table 1. Almost half (41.7%) of the participants were ≥ 65 years of age, 48% were males, and
34.2% were non-Hispanic white. About a quarter (24.5%) of the participants had a household
income under $20,000. The majority of the participants were currently married or living with a
partner (60.0%) and had a high school diploma/GED or greater (62.6%). The mean duration of
their diabetes was nearly 12 years (11.7 ±11.0), with a large variance. Over half of the
participants (54.2%) had an HbA1c ≤ 7, and the mean BMI was 33.7 ± 8.3. Nearly half of the
participants (47.5%) had seen a nurse educator or dietitian not more than a year ago for diabetes
education. Also, 79.4% and 29.9% of the participants reported taking anti-hyperglycemic pills
and insulin, respectively, to lower blood glucose.
Self-monitoring of Blood Glucose (SMBG) According to Marital Status and Gender
Table 2 presents the percentage of participants who self-monitor their blood glucose
levels daily. Sixty-four percent of the sample checked their blood glucose level at least one time
a day, regardless of marital status. Of all the male participants, 60.7% checked their blood
glucose level daily, while 64% of males who were currently married/living with a partner and
52% of those who were not married checked daily. Of all the female participants, 67.6% checked
their blood glucose level daily, while 64.7% of females who were married/living with a partner
and 70.5% of those who were not married checked daily. Marriage is shown to have different
implications for male and female participants, as it seems to have positive effect on
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SMBG behavior among males but not females. Logistic regression analyses establish whether or
not this is a mere coincidence.
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Table 1. Characteristics of the sample (n=465)
Characteristics

n (%)

Age, y
24-34
35-44
45-54
55-64

21 (4.5)
30 (6.5)
78 (16.8)
142 (30.5)
194 (41.7)
224 (48.2)

≥ 65
Male
Race
Mexican American
Black
White
Other Hispanic
Other Race, including Multi-Racial
Education Level
No High School Diploma
High School Diploma/GED or Equivalent
Associate’s Degree/Some College
College Graduate or Above
Income
Under $20,000
Over $20,000
$20,000 to $44,999
$45,000 to $74,999
$75,000 to Over
Marital Status
Married/Living with a Partner
Widowed
Divorced/Separated
Never Married
BMI

99 (21.3)
120 (25.8)
159 (34.2)
57 (12.3)
30 (6.5)
174 (37.4)
92 (19.8)
134 (28.8)
65 (14.0)
114 (24.5)
33 (7.1)
154 (33.1)
92 (19.8)
72 (15.5)
280 (60.2)
63 (13.5)
86 (18.5)
36 (7.7)
33.7 ± 8.3

Duration of Diabetes, y
Education from Diabetes Specialist
1 year ago or less
1 to 5 years ago
More than 5 years ago
Never
HbA1c
7 or Less
Greater than 7
Treatment
Pills
Insulin

	
  

Mean ± SD

11.7 ±11.0
221 (47.5)
78 (16.8)
37 (8.0)
129 (27.7)
252 (54.2)
213 (45.8)
369 (79.4)
139 (29.9)
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Table 2. Percent of participants who self-monitor blood glucose daily

All
Married
Not Married

	
  

All
(n=465)

Male
(n=224)

Female
(n=241)

64.3
64.3
64.3

60.7
64.0
52.4

67.6
64.7
70.5
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Key Determinants of Self-monitoring of Blood Glucose
The results from the binary logistic regression analyses are presented in Table 3. In the
shorter logistic regression, demographics including marital status, along with duration of
diabetes and diabetes education from a nurse educator or dietitian were entered. When the
regression was performed for entire sample, age ≥ 65 (OR = 1.9, P = .016), non-Hispanic white
(OR = 3.4, P = < .001), diabetes education 1 year ago or less (OR = 1.7, P = .023), and duration
of diabetes (OR = 1.0, P < .001) were significant predictors of SMBG. When HbA1c, taking
insulin, and taking pills were added to the regression, age ≥ 65 (OR = 2.5, P = .003), nonHispanic white (OR = 3.1, P = < .001), and diabetes education 1 year ago or less (OR = 1.6, P =
.044) remained significant predictors of SMBG, along with taking insulin (OR = 6.5, P = < .001)
and taking pills (OR = 1.8, P = .034). However, duration of diabetes was no longer statistically
significant (OR = 1.0, P = .208). Marital status was not shown to be a significant predictor of
SMBG (OR = 1.0, P = .432).
When the shorter regression was performed for females only, age 55-64 (OR = 0.8, P =
.031) and age ≥ 65 (OR = 1.0, P = .006)	
  were significant predictors of SMBG. Also, nonHispanic white participants were 7 times as likely as Mexican-American participants to monitor
their blood glucose level (OR = 7.0, P = .036).	
  Duration of diabetes was, also, a significant
predictor (OR = 1.1, P = .011). However, statistical significance did not hold for non-Hispanic
white (OR = 1.7, P = .125) and duration of diabetes (OR = .77, P = .236) when HbA1c, taking
insulin, and taking pills were added to the regression. Age 55-64 (OR = 1.8, P = .010) and age ≥
65 (OR = 3.3, P = .004)	
  remained as statistically significant predictors of SMBG. Female
participants who were taking insulin were greater than 22 times more likely to monitor their
blood glucose level daily (OR = 22.3, P = < .001)	
  and those taking pills were more than twice as
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likely to self-monitor blood glucose (OR = 2.6, P = .033). The regression did not show marital
status as a significant predictor of SMBG among female participants (OR = 0.8, P = .214).
The binary logistic regression was also performed for males only. The shorter regression
revealed currently married/living with a partner as a significant predictor. Participants who were
currently married/living with a partner were nearly twice as likely as those who were unmarried
to self-monitor their blood glucose level at least one time a day (OR =1.9, P = .031).	
  NonHispanic white (OR = 7.0, P = < .001), non-Hispanic black (OR = 3.1, P = .008), and duration of
diabetes (OR = 1.1, P = .001) were statistically significant predictors, also. However, statistical
significance for currently married/living with a partner did not hold when HbA1c, taking insulin,
and taking pills were added to the regression (OR = 1.7, P = .072). Non-Hispanic white (OR =
7.6, P = < .001), non-Hispanic black (OR = 3.4, P = .007), and other race, including multi-racial
(OR = 3.6, P = .048) were significant predictors. Also, the male participants who were taking
insulin were nearly 5 times as likely to self-monitor their blood glucose level daily (OR = 4.8, P
= < .001).
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Table 3. Odds of Predicting Daily Self-monitoring of Blood Glucose

Predictors
Married

All
(n = 465)
Odds
P
Ratio

All
(n = 465)
Odds
P
Ratio

Females
(n = 241)
Odds
P
Ratio

Females
(n = 241)
Odds
P
Ratio

Males
(n = 224)
Odds
P
Ratio

Males
(n = 224)
Odds
P
Ratio

1.0

.437

.96

.432

.75

.181

.76

.214

1.9*

.031

1.7

.072

1.1

.449

.85

.396

1.6

.268

.71

.352

.62

.273

.65

.310

1.4

.223

1.5

.212

1.7

.210

1.1

.448

1.1

.432

1.6

.283

1.4

.119

1.4

.148

2.3*

.031

1.8*

.010

.84

.357

.91

.432

1.9*

.016

2.5*

.003

2.9*

.006

3.3*

.004

.97

.479

1.3

.285

Age, y
24-34
35-44
45-54 (omitted)
55-64
≥ 65
Race
Mexican American (omitted)
Other Hispanic
Non-Hispanic White
Non-Hispanic Black
Other incl. Multi-racial

1.0

.466

1.0

.474

.96

.475

.75

.299

1.3

.310

1.6

.223

3.4*

< .001

3.1*

< .001

2.2*

.036

1.7

.125

7.0*

< .001

7.6*

< .001

1.7

.051

1.6

.063

.97

.476

.78

.293

3.1*

.008

3.4*

.007

1.8

.111

1.9

.099

1.3

.335

1.2

.405

2.8

.069

3.6*

.048

1.4

.144

1.3

.194

1.1

.407

.91

.425

1.6

.162

1.5

.187

1.1

.408

.87

.333

1.1

.421

.70

.233

.84

.354

.73

.263

1.1

.368

1.1

.434

1.4

.274

1.3

.329

.75

.296

.74

.295

1.4

.112

1.4

.109

1.2

.329

1.2

.335

1.3

.257

1.3

.271

1.7*

.023

1.6*

.044

1.6

.109

1.4

.179

1.8

.059

1.8

.071

1.3

.215

1.3

.204

1.3

.255

1.5

.210

1.1

.444

1.1

.456

0.9

.413

.73

.246

.64

.231

.47

.128

1.5

.276

1.2

.403

1.0*

< .001

1.0

.208

1.0*

.011

1.0

.413

1.1*

.001

1.0

.128

.81

.197

.77

.236

.81

.280

6.5*

< .001

22.3*

< .001

4.8*

< .001

1.8*

.034

2.6*

.033

1.96

.083

Education
No High School Diploma
High School Diploma/GED (omitted)
Some College/Assoc.’s Degree
Bachelor’s Degree or Greater
Income
Under $20,000
≥ $20,000 (omitted)
Education from Diabetes Specialist
1 year ago or less
1 to 5 years ago
More than 5 years ago
Never (omitted)
Duration of Diabetes, y
HbA1c ≤ 7
HbA1c > 7 (omitted)
Treatment
Insulin
Pills
-2 Log likelihood

549.454

509.954

275.863

244.399

256.592

241.400

Notes: Data come from the continuous National Health and Nutrition Examination Survey (NHANES) 2009 – 2010. The sample consists of adults (ages 20-79) with diabetes mellitus in the U.S.
population.
*P < .05
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CHAPTER V - DISCUSSION
This data indicates that approximately one-third (36%) of adults with diabetes in the U.S.
population do not self-monitor their blood glucose level at least 1 time/day. Additionally, 32%
females and 39% of males with diabetes do not self-monitor 1 time/day. More specifically,
29.5% of females who are not married do not self-monitor daily, and this is true for an even
greater number (47.6%) of males who are not married. The results of this study mirror that of a
previous national study of SMBG, revealing the use of insulin as a major determinant, especially
among females (Harris et al., 1993).
Besides insulin use, there were other significant predictors of daily SMBG including age,
race/ethnicity, and DM patient education. Among all participants, those who were ≥ 65 years
were twice as likely to self-monitor daily than those who were ages 24-34. This differs from the
findings of previous studies, which show a trend of decreasing odds of SMBG with increasing
age (Evans et al., 1999; Harris et al., 1993). Non-Hispanic whites were 3 times more likely to
self-monitor 1 time/day compared with Mexican Americans. Also, those who had patient DM
education from a nurse educator or dietitian within the past 12 months were nearly twice as
likely to self-monitor daily than those who never received patient DM education. The
significance of the variable, duration of diabetes, did not sustain after controlling for the types of
treatment including the use of insulin and oral anti-hyperglycemic pills. Also, income and
education were not significantly related to daily SMBG.
Marriage has been shown to have protective effects as it relates to health and mortality. It
is the belief that marriage protects against death through emphasis on health, risk reduction, and
compliance with medical regimens (Rogers, 1995). Married persons have been shown to have
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lower risks of death compared to non-married persons, even after adjusting for additional
socioeconomic variables (Johnson, Backlund, Sorlie, & Loveless, 2000). Since SMBG is a
technique or regimen used by individuals with diabetes to prevent or delay morbidity and
mortality, it is useful to examine the relationship between marital status and SMBG. However,
marriage was independently related to SMBG for males only, when the use of insulin and pills
were not included in the logistic regression. Moreover, the significance for marriage as a
predictor among males was dissolved after controlling for the use of insulin and antihyperglycemic pills (P = .072). Marital status was not shown to be a significant predictor of
SMBG in females or any other instance.
Men and women are believed to have vast mortality differences as it relates to marital
status. Some studies report marriage protection for males and females (Lillard & Waite, 1995),
females only (Zick & Smith, 1991), and no difference for old-age mortality (Manzoli et al.,
2007). Another study reports marriage protection and marriage selection effects for women who
were not employed full-time (Waldron, Hughes, & Brooks, 1996). Also, divorced men have been
shown to have the highest death rates among unmarried groups (Hu & Goldman, 1990).
However, it has been suggested that gender mortality differences, as they relate to marital status,
become smaller when employment and number of children are considered (Hemström, 1996). In
order to examine the differences between males and females, the relationship between several
predictors and daily SMBG was analyzed, separately, for each gender. Age was independently
related to SMBG among females, along with using insulin and taking anti-hyperglycemic pills.
Among males, however, race and insulin use were significant predictors of SMBG.
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Implications
The ultimate goal of SMBG is to achieve optimal glycemic control and prevent
complications and mortality associated with DM. Since hyperglycemia and poor glycemic
control is associated with several diabetes-related complications, such as retinopathy,
neuropathy, and nephropathy, achieving glycemic control is the single most important aspect of
disease management for individuals with diabetes. SMBG is used to help achieve glycemic
control by providing knowledge of day-to-day glycemic ranges and illuminating problems with
treatment. Also, the prevention or delay of further complications contributes to cost-savings, as
costly conditions such as blindness and end-stage renal disease (ESRD) often occur as a result of
poorly controlled diabetes. Physicians, nutrition practitioners, and diabetes nurse educators
should continue to place emphasis on the use of SMBG, especially among younger adults, those
who have not received DM education within the past year, and those who do not use insulin.
Study Limitations
In this continuous NHANES data 2009-2010, it was not possible to differentiate between
those with T1DM and T2DM. Analyzing this data by the type of diabetes may reveal more
useful findings. Additionally, this study does not examine the relationship between SMBG and
glycemic control and, therefore, does not address whether those who self-monitor daily have
better glycemic control than those who do not self-monitor. Likewise, this study does not address
whether marital status determines glycemic control differently for males and females. These
topics should be the focus of future research.
Conclusions
In conclusion, one-third of the U.S. adults with diabetes do not self-monitor blood
glucose at least 1 time/day. Insulin is the main predictor of daily SMBG, while the odds of daily
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SMBG increase with age. Other significant predictors of SMBG are race/ethnicity and patient
DM education. There are differences among determinants of SMBG for males and females.
While age, race, insulin use, and taking anti-hyperglycemic pills determine SMBG for females,
only race and insulin use determine SMBG for males. Although marital status is independently
associated with reduced mortality, a similar protective relationship is not shown between marital
status and SMBG. Since SMBG may be useful in the achievement of glycemic control,
individuals with diabetes should incorporate this practice into their regimens for diabetes selfmanagement.
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